Vitamin D treatment for the prevention of falls in older adults: systematic review and meta-analysis.
Vitamin D treatment for the prevention of falls in older adults: systematic review and meta-analysis.
复制标题
DOI:
10.1111/j.1532-5415.2010.02949.x
复制
发表时间:
2010-07
影响因子:
6.3
通讯作者:
Crews DC
中科院分区:
文献类型:
--
作者:
Kalyani RR;Stein B;Valiyil R;Manno R;Maynard JW;Crews DC
To systematically review and quantitatively synthesize the effect of vitamin D therapy on fall prevention in older adults. Systematic review and meta-analysis. MEDLINE, CINAHL,Web of Science, EMBASE, Cochrane Library, LILACS, bibliographies of selected articles, and previous systematic reviews through February 2009 were searched for eligible studies. Older adults (aged ≥60 years) who participated in randomized controlled trials that investigated the effectiveness of vitamin D therapy in the prevention of falls and used an explicit fall definition. Two authors independently extracted data including study characteristics, quality assessment, and outcomes. The I2 statistic was used to assess heterogeneity in a randomeffects model. Of 1,679 potentially relevant articles, 10 studies met inclusion criteria. In pooled analysis, vitamin D therapy (200-1000IU) reduced falls by 14% (relative risk [RR] 0.86;95% confidence interval 0.79-0.93;I2=7%) compared to calcium or placebo; number needed to treat=15. The following subgroups had significant fall reductions: community-dwelling (age<80 years), adjunctive calcium supplementation, no history of fractures/falls, duration>6 months, cholecalciferol, and dose≥800 IU. Meta-regression demonstrated no linear association of vitamin D dose or duration with treatment effect. Post-hoc analysis, including 7 additional studies (17 total) without explicit fall definitions, yielded smaller benefit (RR 0.92,0.87-0.98) and more heterogeneity (I2=36%) but found significant intergroup differences favoring adjunctive calcium versus none (p=0.001). Vitamin D treatment effectively reduces the risk of falls in older adults. Future studies should investigate whether particular populations or treatment regimens may have greater benefit.
登录
查看更多内容
影响因子:
4.3
作者:
Holick, Michael F
通讯作者:
Holick, Michael F
影响因子:
6.7
作者:
Harwood, RH;Sahota, O;Hosking, DJ
通讯作者:
Hosking, DJ
影响因子:
6.7
作者:
CAMPBELL, AJ;BORRIE, MJ;FITZGERALD, JL
通讯作者:
FITZGERALD, JL
影响因子:
6.2
作者:
Bischoff, HA;Stähelin, HB;Conzelmann, M
通讯作者:
Conzelmann, M
DOI:
10.1111/j.1532-5415.2007.01048.x
发表时间:
2007-02-01
影响因子:
6.3
作者:
Broe, Kerry E.;Chen, Tai C.;Kiel, Douglas P.
通讯作者:
Kiel, Douglas P.